BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 29507658)

  • 1. Elevation of autoantibody level against PDCD11 in patients with transient ischemic attack.
    Yoshida Y; Wang H; Hiwasa T; Machida T; Kobayashi E; Mine S; Tomiyoshi G; Nakamura R; Shinmen N; Kuroda H; Takizawa H; Kashiwado K; Kamitsukasa I; Shin H; Wada T; Aotsuka A; Nishi E; Ohno M; Takemoto M; Yokote K; Takahashi S; Matsushima J; Zhang XM; Takiguchi M; Iwadate Y
    Oncotarget; 2018 Feb; 9(10):8836-8848. PubMed ID: 29507658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of serum levels of antibodies against ALDOA and FH4 with transient ischemic attack and cerebral infarction.
    Wang H; Lu H; Zhang XM; Goto KI; Kobayashi E; Yoshida Y; Adachi A; Matsutani T; Iwadate Y; Mine S; Machida T; Sata M; Yamagishi K; Iso H; Sawada N; Tsugane S; Kamitsukasa I; Wada T; Aotsuka A; Sugimoto K; Takizawa H; Kashiwado K; Shin H; Tomiyoshi G; Nakamura R; Shinmen N; Kuroda H; Xu A; Hiwasa T
    BMC Neurol; 2021 Jul; 21(1):274. PubMed ID: 34243715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated levels of autoantibodies against DNAJC2 in sera of patients with atherosclerotic diseases.
    Yoshida Y; Zhang XM; Wang H; Machida T; Mine S; Kobayashi E; Adachi A; Matsutani T; Kamitsukasa I; Wada T; Aotsuka A; Iwase K; Tomiyoshi G; Nakamura R; Shinmen N; Kuroda H; Takizawa H; Kashiwado K; Shin H; Akaogi Y; Shimada J; Nishi E; Ohno M; Takemoto M; Yokote K; Kitamura K; Iwadate Y; Hiwasa T
    Heliyon; 2020 Aug; 6(8):e04661. PubMed ID: 32904265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevation of Autoantibody in Patients with Ischemic Stroke.
    Yoshida Y; Hiwasa T; Machida T; Kobayashi E; Mine S; Matsushima J; Takiguchi M; Iwadate Y
    Neurol Med Chir (Tokyo); 2018 Jul; 58(7):303-310. PubMed ID: 29848906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of serum levels of antibodies against MMP1, CBX1, and CBX5 with transient ischemic attack and cerebral infarction.
    Wang H; Zhang XM; Tomiyoshi G; Nakamura R; Shinmen N; Kuroda H; Kimura R; Mine S; Kamitsukasa I; Wada T; Aotsuka A; Yoshida Y; Kobayashi E; Matsutani T; Iwadate Y; Sugimoto K; Mori M; Uzawa A; Muto M; Kuwabara S; Takemoto M; Kobayashi K; Kawamura H; Ishibashi R; Yokote K; Ohno M; Chen PM; Nishi E; Ono K; Kimura T; Machida T; Takizawa H; Kashiwado K; Shimada H; Ito M; Goto KI; Iwase K; Ashino H; Taira A; Arita E; Takiguchi M; Hiwasa T
    Oncotarget; 2018 Jan; 9(5):5600-5613. PubMed ID: 29464021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum anti-DIDO1, anti-CPSF2, and anti-FOXJ2 antibodies as predictive risk markers for acute ischemic stroke.
    Hiwasa T; Wang H; Goto KI; Mine S; Machida T; Kobayashi E; Yoshida Y; Adachi A; Matsutani T; Sata M; Yamagishi K; Iso H; Sawada N; Tsugane S; Kunimatsu M; Kamitsukasa I; Mori M; Sugimoto K; Uzawa A; Muto M; Kuwabara S; Kobayashi Y; Ohno M; Nishi E; Hattori A; Yamamoto M; Maezawa Y; Kobayashi K; Ishibashi R; Takemoto M; Yokote K; Takizawa H; Kishimoto T; Matsushita K; Kobayashi S; Nomura F; Arasawa T; Kagaya A; Maruyama T; Matsubara H; Tomiita M; Hamanaka S; Imai Y; Nakagawa T; Kato N; Terada J; Matsumura T; Katsumata Y; Naito A; Tanabe N; Sakao S; Tatsumi K; Ito M; Shiratori F; Sumazaki M; Yajima S; Shimada H; Shirouzu M; Yokoyama S; Kudo T; Doi H; Iwase K; Ashino H; Li SY; Kubota M; Tomiyoshi G; Shinmen N; Nakamura R; Kuroda H; Iwadate Y
    BMC Med; 2021 Jun; 19(1):131. PubMed ID: 34103026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum anti-SERPINE1 antibody as a potential biomarker of acute cerebral infarction.
    Kubota M; Yoshida Y; Kobayashi E; Matsutani T; Li SY; Zhang BS; Mine S; Machida T; Takizawa H; Hiwasa T; Iwadate Y
    Sci Rep; 2021 Nov; 11(1):21772. PubMed ID: 34741085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum anti-PCK1 antibody levels are a prognostic factor for patients with diabetes mellitus.
    Namiki T; Takemoto M; Hayashi A; Yamagata H; Ishikawa T; Yokote K; Li SY; Kubota M; Zhang BS; Yoshida Y; Matsutani T; Mine S; Machida T; Kobayashi Y; Terada J; Naito A; Tatsumi K; Takizawa H; Nakamura R; Kuroda H; Iwadate Y; Hiwasa T
    BMC Endocr Disord; 2023 Oct; 23(1):239. PubMed ID: 37904164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of stroke-associated-antigens via screening of recombinant proteins from the human expression cDNA library (SEREX).
    Machida T; Kubota M; Kobayashi E; Iwadate Y; Saeki N; Yamaura A; Nomura F; Takiguchi M; Hiwasa T
    J Transl Med; 2015 Feb; 13():71. PubMed ID: 25890248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Anti-BRAT1 is a Common Molecular Biomarker for Gastrointestinal Cancers and Atherosclerosis.
    Hu L; Liu J; Shimada H; Ito M; Sugimoto K; Hiwasa T; Zhou Q; Li J; Shen S; Wang H
    Front Oncol; 2022; 12():870086. PubMed ID: 35656505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation between the metabolic syndrome and ischemic stroke or transient ischemic attack: a prospective cohort study in patients with atherosclerotic cardiovascular disease.
    Koren-Morag N; Goldbourt U; Tanne D
    Stroke; 2005 Jul; 36(7):1366-71. PubMed ID: 15933253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood test detecting autoantibodies to N-methyl-D-aspartate neuroreceptors for evaluation of patients with transient ischemic attack and stroke.
    Dambinova SA; Khounteev GA; Izykenova GA; Zavolokov IG; Ilyukhina AY; Skoromets AA
    Clin Chem; 2003 Oct; 49(10):1752-62. PubMed ID: 14500616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is isolated aphasia a typical presentation of presumed cardioembolic transient ischemic attack or stroke?
    Fennis TF; Compter A; van den Broek MW; Koudstaal PJ; Algra A; Koehler PJ
    Cerebrovasc Dis; 2013; 35(4):337-40. PubMed ID: 23615539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum anti‑TSTD2 antibody as a biomarker for atherosclerosis‑induced ischemic stroke and chronic kidney disease.
    Kubota M; Zhang BS; Li SY; Yoshida Y; Wang H; Adachi A; Matsutani T; Mine S; Machida T; Kamitsukasa I; Wada T; Aotsuka A; Kitamura K; Takizawa H; Kuroda H; Iwadate Y; Hiwasa T
    Med Int (Lond); 2023; 3(1):4. PubMed ID: 36699658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neuroprotection of prodromal transient ischaemic attack on cerebral infarction.
    Fu Y; Sun JL; Ma JF; Geng X; Sun J; Liu JR; Song YJ; Chen SD
    Eur J Neurol; 2008 Aug; 15(8):797-801. PubMed ID: 18505406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of early stroke recurrence in transient ischemic attack patients from the PROMAPA study: a comparison of prognostic risk scores.
    Purroy F; Jiménez Caballero PE; Gorospe A; Torres MJ; Alvarez-Sabin J; Santamarina E; Martínez-Sánchez P; Cánovas D; Freijo MM; Egido JA; Girón JM; Ramírez-Moreno JM; Alonso A; Rodríguez-Campello A; Casado I; Delgado-Medeiros R; Martí-Fàbregas J; Fuentes B; Silva Y; Quesada H; Cardona P; Morales A; de la Ossa N; García-Pastor A; Arenillas JF; Segura T; Jiménez C; Masjuán J;
    Cerebrovasc Dis; 2012; 33(2):182-9. PubMed ID: 22237056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel TIA biomarkers identified by mass spectrometry-based proteomics.
    George PM; Mlynash M; Adams CM; Kuo CJ; Albers GW; Olivot JM
    Int J Stroke; 2015 Dec; 10(8):1204-11. PubMed ID: 26307429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of the ABCD2 score beyond short-term follow-up after transient ischemic attack (TIA)--a cohort study.
    Holzer K; Feurer R; Sadikovic S; Esposito L; Bockelbrink A; Sander D; Hemmer B; Poppert H
    BMC Neurol; 2010 Jun; 10():50. PubMed ID: 20565966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of Subsequent Stroke Among Patients Receiving Outpatient vs Inpatient Care for Transient Ischemic Attack: A Systematic Review and Meta-analysis.
    Shahjouei S; Li J; Koza E; Abedi V; Sadr AV; Chen Q; Mowla A; Griffin P; Ranta A; Zand R
    JAMA Netw Open; 2022 Jan; 5(1):e2136644. PubMed ID: 34985520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of atherosclerosis-associated serum antibodies against colony-stimulating factor 2 in predicting the onset of acute ischemic stroke and prognosis of colorectal cancer.
    Li SY; Yoshida Y; Kubota M; Zhang BS; Matsutani T; Ito M; Yajima S; Yoshida K; Mine S; Machida T; Hayashi A; Takemoto M; Yokote K; Ohno M; Nishi E; Kitamura K; Kamitsukasa I; Takizawa H; Sata M; Yamagishi K; Iso H; Sawada N; Tsugane S; Iwase K; Shimada H; Iwadate Y; Hiwasa T
    Front Cardiovasc Med; 2023; 10():1042272. PubMed ID: 36844744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.